Exatecan Mesylate (DX-8951f) is a potent inhibitor of DNA topoisomerase I, exhibiting an IC50 of 2.2 µM. This camptothecin analog has demonstrated antitumor activity in both in vitro cytotoxicity assays and in vivo xenograft models, supporting its research use in oncology and cancer pharmacology.